Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease
Schwarz M, Scholz S, Beck E, Meszaros K, Schneider M, Ultsch B, Greiner W (2020)
Value in health 23(Suppl. 2): S698.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Schwarz, M.;
Scholz, S.;
Beck, E.;
Meszaros, K.;
Schneider, M.;
Ultsch, B.;
Greiner, WolfgangUniBi
Einrichtung
Erscheinungsjahr
2020
Serien- oder Zeitschriftentitel
Value in health
Band
23
Ausgabe
Suppl. 2
Seite(n)
S698
ISSN
1098-3015
eISSN
1524-4733
Page URI
https://pub.uni-bielefeld.de/record/2952139
Zitieren
Schwarz M, Scholz S, Beck E, et al. Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease. Value in health. 2020;23(Suppl. 2):S698.
Schwarz, M., Scholz, S., Beck, E., Meszaros, K., Schneider, M., Ultsch, B., & Greiner, W. (2020). Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease. Value in health, 23(Suppl. 2), S698. https://doi.org/10.1016/j.jval.2020.08.1784
Schwarz, M., Scholz, S., Beck, E., Meszaros, K., Schneider, M., Ultsch, B., and Greiner, Wolfgang. 2020. “Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease”, Value in health, 23 (Suppl. 2): S698.
Schwarz, M., Scholz, S., Beck, E., Meszaros, K., Schneider, M., Ultsch, B., and Greiner, W. (2020). Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease. Value in health 23, S698.
Schwarz, M., et al., 2020. Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease. Value in health, 23(Suppl. 2), p S698.
M. Schwarz, et al., “Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease”, Value in health, vol. 23, 2020, pp. S698.
Schwarz, M., Scholz, S., Beck, E., Meszaros, K., Schneider, M., Ultsch, B., Greiner, W.: Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease. Value in health. 23, S698 (2020).
Schwarz, M., Scholz, S., Beck, E., Meszaros, K., Schneider, M., Ultsch, B., and Greiner, Wolfgang. “Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease”. Value in health 23.Suppl. 2 (2020): S698.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar